Triple-Negative Breast Cancer
Targeting the Untargetable: New Antibody Disrupts Key Protein in Aggressive Breast Cancer
Researchers at MUSC Hollings Cancer Center have developed an antibody targeting the SFRP2 protein, opening a new front in the battle against triple-negative breast cancer.
